Welcome to our company blog! We’re excited to announce the launch of this entirely new resource created specifically for our loyal ACD/Labs followers. Our posts will appear every few weeks, and they will include new thought provoking content, exclusive company news, and (most importantly) fun and entertaining updates from the ACD/Labs team.
Considering today is our first post, we thought we’d start off with some good news! We’d like to take this opportunity to introduce Andrew Anderson, our new VP of Business Development. Andrew joins ACD/Labs from PepsiCo, Symyx before that, and…well… ACD/Labs. Andrew’s most recent experience was in Technology Licensing at PepsiCo, where he spent 4 years in the R&D Technology Scouting Group. Prior to PepsiCo, Andrew spent nearly 10 years in various Sales, Sales Management, and Strategic Partnership Roles at ACD/Labs and Symyx.
In the coming weeks, Andrew will share his thoughts on the current state of informatics in R&D and ACD/Labs’ plans for future development. Until then, we’d like to give you a sense of who else you’ll be hearing from in the coming weeks, including guest blogs from individuals not listed below.
Graham A. McGibbon is ACD/Labs’ Manager, Strategic Partnerships & Scientific Solutions and his role includes communication with third-parties to develop successful, long term, strategic relationships and collaborations leading to software innovations for customers. He also works with scientists in various industries, government organizations, and academic institutions to understand their R&D workflows and software requirements. Graham has a Ph.D. in analytical chemistry and his career has included software product management and research stints in academia, scientific instrumentation, and big pharma.
Karim has been with ACD/Labs for over 12 years and is currently responsible for managing the global Technical and Scientific Services (TSS) team at ACD/Labs. In addition, he has recently taken on the responsibility to ensure that customers succeed with the software and solutions in which they’ve invested.
Karim joined ACD/Labs from GlycoDesign Inc. where he was a medicinal chemist, working to discover novel small molecule carbohydrate processing inhibitors, following his Ph.D. in Physical Organic/Synthetic Chemistry from McMaster University.
Each post will provide a new perspective from a thought leader in the industry or department within ACD/Labs. For the most part, the topics will depend on current industry events, trends and conferences, but we’d also like to hear from you!
Our goal for the remainder of 2015 and beyond is to provide a helpful resource for our customers that is insightful, informative, and fun. So with that in mind…have an idea for a blog post? Interested in learning more about a specific topic or ACD/Labs product? Share your thoughts with us in the comment section below, and we’ll do our best to answer any questions you may have.
In the meantime, we have prepared a lot of exciting content for the coming weeks so be sure to check-in regularly. Thank you for your continued support of ACD/Labs and we hope to see you again soon!